IMC Chicago’s Rentokil RTO Stock Holding History

IMC Chicago’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Buy	9,700 +2,900	+43%	+$92K	﹤0.01%	5309
2026 Q1	$214K	Buy	+6,800	New	+$214K	﹤0.01%	4942

Other funds holding RTO

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

IMC Chicago's RTO Position: Q2 2026 in Review

IMC Chicago increased its Rentokil (RTO) stake by 199% in Q2 2026, buying an estimated $453K and bringing the position to 21,444 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #4410.

IMC Chicago first reported a position in RTO in Q1 2026 and has held it in 2 quarters since. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

IMC Chicago held 21,444 shares of Rentokil worth $614K as of Q2 2026.
IMC Chicago bought 14,272 Rentokil shares in Q2 2026, an estimated $453K.
Rentokil made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4410 holding.
IMC Chicago first reported a position in Rentokil in Q1 2026 and has held it in 2 quarters since.
284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.